SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein
Selected Variant
GTR18911873
Size: 0.025 mg
SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein
Product Specifications
Product Name Alternative
SARS-CoV-2 (COVID-19) Spike Recombinant Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein
UniProt
P0DTC2
Tag
C-terminal Rho1D4
Source
HEK293 cells
Field of Research
Infectious Disease & Virology
Concentration
Batch dependent
Purity
>98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Rho1D4 Agarose.
Bioactivity
Not determined
Form
Liquid
Molecular Weight
1286 amino acids (including Rho1D4 tag and linker) ; 142115.37 Da
Storage Conditions
–80°C. Avoid freeze-thaw cycles
Notes
For research use only.
Applications Notes
This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.
Tested Applications
ELISA
Preservative
20 mM Hepes pH 7.5; 150 mM NaCl, 0.001 % LMNG
AA Sequence
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD63 (Mouse) Recombinant Monoclonal Rat Antibody (24MS05.63), CF®405M Conjugate - Biotium Choice
Bcl-X (Apoptosis Marker) (BCL2L1/1762), CF488A conjugate, 0.1mg/mL
TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF568 conjugate, 0.1mg/mL
MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146 (MCAM/3046), 0.2mg/mL
Anti-PSD3 Antibody Picoband®, Carrier-free
